Kandace Saberhagen has been working with a huge scientific team working to further our world of stem cell therapy. She always on a quest to find the protocols using the best products because our patients are becoming smarter and learning how to do research for themselves. Regarding our latest debacle in virus protection, her team went right to work to help assist both here and in China.
As it turns out, stem cell therapy when treated systemically using the correct product can help fight or prevent.
BUT product matters.
You need high cell counts!
Biogenix offers 30 million MSCs per vial and those are infused MSCs. If you have patients who are interested, let us know!
The research based articles mention that stem cell therapy represents a therapeutic option to fight the virus and increase survival while effective vaccines are being developed. Some of these articles even mention about a few COVID patients in China who received stem cell therapy and were subsequently discharged from the hospital.
But the main premise of the articles revolves around preventative medicine for those not infected yet. Although these are prelim findings, according to the research, there is evidence to support that infected patients may be more likely to combat and survive infection principally due by the immunomodulation and regenerative potential. Here are some articles for your reference…
- https://www.straitstimes.com/asia/east-asia/coronavirus-china-looking-at-using-stem-cell-therapy-to-treat-severe-cases
- https://bioinst.com/en/covid-19-mesenchymal-stem-cells-effective-against-sars-cov-2/
- https://clinicaltrials.gov/ct2/show/NCT04252118
- https://www.jpost.com/HEALTH-SCIENCE/Israeli-cell-therapy-to-treat-acute-COVID-19-patients-prevent-ARDS-621016
- https://www.bioportfolio.com/news/article/4235638/Stem-Cell-Therapy-for-Coronavirus-Infection.html
- https://www.bioportfolio.com/resources/trial/265822/Treatment-With-Mesenchymal-Stem-Cells-for-Severe-Corona-Virus-Disease-2019-COVID.html
- http://chinaxiv.org/abs/202002.00084
- http://chinaxiv.org/abs/202002.00080
- https://www.bioportfolio.com/news/article/4251604/Celltex-Plans-to-Launch-Program-to-Use-Mesenchymal-Stem-Cells-for-COVID.html